Diagnos Stock Analysis
| ADK Stock | CAD 0.31 0.01 3.13% |
Diagnos is overvalued with Real Value of 0.26 and Hype Value of 0.31. The main objective of Diagnos stock analysis is to determine its intrinsic value, which is an estimate of what Diagnos is worth, separate from its market price. There are two main types of Diagnos' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Diagnos' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Diagnos' stock to identify patterns and trends that may indicate its future price movements.
The Diagnos stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Diagnos is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Diagnos Stock trading window is adjusted to America/Toronto timezone.
Diagnos |
Diagnos Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Diagnos last dividend was issued on the 24th of April 2019. The entity had 1:10 split on the 24th of April 2019. DIAGNOS Inc. provides software-based interpretation services in Canada, the United States, Kenya, the United Arab Emirates, Saudi Arabia, Mexico, and internationally. The company was founded in 1998 and is headquartered in Brossard, Canada. DIAGNOS INC operates under Health Information Services classification in Canada and is traded on TSX Venture Exchange. For more info on Diagnos please contact Andre Larente at 450 678 8882 or go to https://www.diagnos.ca.Diagnos Investment Alerts
| Diagnos generated a negative expected return over the last 90 days | |
| Diagnos has some characteristics of a very speculative penny stock | |
| Diagnos has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 170.16 K. Net Loss for the year was (3.12 M) with loss before overhead, payroll, taxes, and interest of (306.77 K). | |
| Diagnos has accumulated about 97.5 K in cash with (2.41 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Suraksha Diagnostic shares list at 1 percent discount over IPO price - The Economic Times |
Diagnos Largest EPS Surprises
Earnings surprises can significantly impact Diagnos' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-21 | 2024-06-30 | -0.02 | -0.01 | 0.01 | 50 |
Diagnos Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 29.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diagnos's market, we take the total number of its shares issued and multiply it by Diagnos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Diagnos Profitablity
Diagnos' profitability indicators refer to fundamental financial ratios that showcase Diagnos' ability to generate income relative to its revenue or operating costs. If, let's say, Diagnos is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Diagnos' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Diagnos' profitability requires more research than a typical breakdown of Diagnos' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.70) | (4.47) | |
| Return On Capital Employed | 2.80 | 2.66 | |
| Return On Assets | (4.70) | (4.47) | |
| Return On Equity | 1.02 | 1.02 |
Management Efficiency
Diagnos has return on total asset (ROA) of (1.3433) % which means that it has lost $1.3433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (24.5157) %, meaning that it generated substantial loss on money invested by shareholders. Diagnos' management efficiency ratios could be used to measure how well Diagnos manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -4.47 in 2024. Return On Capital Employed is likely to drop to 2.66 in 2024. At this time, Diagnos' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 27.6 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 256.8 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.04) | (0.04) | |
| Tangible Book Value Per Share | (0.04) | (0.04) | |
| Enterprise Value Over EBITDA | (9.40) | (9.87) | |
| Price Book Value Ratio | (6.56) | (6.89) | |
| Enterprise Value Multiple | (9.40) | (9.87) | |
| Price Fair Value | (6.56) | (6.89) | |
| Enterprise Value | 23 M | 24.1 M |
Leadership effectiveness at Diagnos is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (15.76) | Beta (0.46) | Return On Assets (1.34) | Return On Equity (24.52) |
Technical Drivers
As of the 13th of December 2024, Diagnos shows the Coefficient Of Variation of (2,306), standard deviation of 3.13, and Mean Deviation of 2.1. Diagnos technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Diagnos standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Diagnos is priced favorably, providing market reflects its regular price of 0.31 per share.Diagnos Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Diagnos middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Diagnos. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Diagnos Outstanding Bonds
Diagnos issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Diagnos uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Diagnos bonds can be classified according to their maturity, which is the date when Diagnos has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Diagnos Predictive Daily Indicators
Diagnos intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Diagnos stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 8734.38 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.32 | |||
| Day Typical Price | 0.31 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Diagnos Forecast Models
Diagnos' time-series forecasting models are one of many Diagnos' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Diagnos' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Diagnos Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Diagnos prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Diagnos shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Diagnos. By using and applying Diagnos Stock analysis, traders can create a robust methodology for identifying Diagnos entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (18.34) | (19.26) | |
| Operating Profit Margin | (15.78) | (16.57) | |
| Net Loss | (18.34) | (19.26) | |
| Gross Profit Margin | 0.21 | 0.22 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Diagnos to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.